arrow
H

Hanna Koseła-Paterczyk

Medical University of Warsaw
H指数:20
被引数:1,352

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Extraskeletal mesenchymal chondrosarcoma: oligometastatic disease and effect of multimodal treatment

Remiszewski, P.; Spałek, M.J.; Koseła-Paterczyk, H.; Wągrodzki, M.; Kalinowska, I.; Rutkowski, P.; Czarnecka, A.M. 骨外间充质软骨肉瘤:寡转移性疾病及多模式治疗效果。Oncol. Clin. Pract. 2025. [Google Scholar] [CrossRef]

2025-09-011
OAAI
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers

如何促进超罕见肿瘤的新疗法开发?EMA-EORTC多利益相关方联合研讨会以超罕见肉瘤作为罕见癌症的模型

2025-08-060
PRE
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)

抗PD-1疗法在儿童和青少年黑色素瘤患者中的疗效(MELCAYA研究)

2024-09-010
PRE
Low-grade fi bromyxoid sarcoma and sclerosing epithelioid fi brosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group
2024-09-010
OAAI
A practical approach to the 2022 ESC cardio-oncology guidelines: Comments by a team of experts - cardiologists and oncologists
2023-10-3112
OA
Combined Preoperative Hypofractionated Radiotherapy With Doxorubicin-Ifosfamide Chemotherapy in Marginally Resectable Soft Tissue Sarcomas: Results of a Phase 2 Clinical Trial
2021-07-0121
PRE
The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice

常规治疗高危分子分型胃肠道间质瘤 (GIST) 患者3年伊马替尼辅助治疗分析

EJSO
IF2.9
2021-05-018
PREAI